2-deoxy-D-glucose approved by DGCI

  • IASbaba
  • May 10, 2021
  • 0
UPSC Articles
Print Friendly, PDF & Email

2-deoxy-D-glucose approved by DGCI

Part of: GS Prelims and GS – II – Health; GS- III – Sci & tech

In news

  • Drugs Controller General of India (DCGI) approved anti-COVID drug 2-deoxy-D-glucose  for emergency use.
  • Developed by: Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad.

Key takeaways

  • Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
  • Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients. 
  • The drug will be of immense benefit to the people suffering from COVID-19.
  • The drug comes in powder form in sachet, which is taken orally by dissolving it in water. 
  • It accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production. 
  • Its selective accumulation in virally infected cells makes this drug unique.

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel – https://t.me/IASbabaOfficialAccount

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....

Sign Up To Receive Regular Updates